Therefore, the aim of this study was to demonstrate the predictive capacity of inflammatory serum biomarkers (hs-CRP, MMP-9, IL-6, adhesion molecules) in association with angiographical parameters characterizing the severity of CAD and LV function, in predicting MACE over the course of a one-year follow-up period, in patients with revascularized AMI (STEMI and NSTEMI). The gene discussed is MMP9; the disease is coronary artery disorder.